← Dashboard
Sep 16, 2026 08:17 PM ET
Catalyst
FDA/Bio
TELIX PHARMACEUTICALS: 'BUY' ON PIXCLARA FDA APPROVAL AND TLX591-TX PART 2 ADVANCEMENT - SEEKINGALPHA
FDA approval of Pixclara and TLX591-Tx Part 2 advancement drive buy rating.
What changed
FDA approval of Pixclara and TLX591-Tx Part 2 advancement drive buy rating.
Why it matters
FDA approval of Pixclara and TLX591-Tx Part 2 advancement drive buy rating. — impact context not separately stored; see What changed.
Sources
seekingalpha
Related signals
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →
PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →
UNICYCIVE PLUMMETS FOLLOWING SECOND CRL FOR OLC FOR HYPERPHOSPHATEMIA - SEEKINGALPHA →